Ikuko Sagara
Overview
Explore the profile of Ikuko Sagara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukuhara-Makiyama N, Hayashida M, Kobayashi M, Sagara I, Ogawa S, Maeda M, et al.
PLoS One
. 2021 Mar;
16(3):e0248833.
PMID: 33750962
In Europe and America, associations between personality traits and body-mass index (BMI) have been reported. However, in Japan, the association between personality traits and BMI (i.e., thinness and obesity) has...
2.
Matsuzaka Y, Hamaguchi Y, Nishino A, Muta K, Sagara I, Ishii H, et al.
Int J Med Educ
. 2020 Nov;
11:240-244.
PMID: 33170147
Objectives: The purpose of this study is to investigate the relationship between medical student readiness for interprofessional learning and interest in community medicine prior to incorporating community-oriented interprofessional education into...
3.
Kobayashi M, Ogawa S, Tayama J, Sagara I, Takeoka A, Bernick P, et al.
Medicine (Baltimore)
. 2020 Sep;
99(37):e22202.
PMID: 32925796
Metabolic syndrome (MetS), mainly caused by intra-abdominal fat (IAF) accumulation, is an important risk factor for cardiovascular disease. The prevalence of MetS increases rapidly after the age of 40 years,...
4.
Niri T, Horie I, Ando T, Kawahara H, Ueda M, Eto M, et al.
Endocr Pract
. 2019 Oct;
26(2):197-206.
PMID: 31652100
Hypothyroidism is not commonly considered a cause of hyperkalemia. We previously reported that hyperkalemia was observed mainly in elderly patients treated with renin-angiotensin-aldosterone system (RAS) inhibitors when levothyroxine treatment was...
5.
Taniguchi Y, Sagara I, Nagata Y, Kikukawa Y, Sasaki S
Chem Pharm Bull (Tokyo)
. 2019 Oct;
67(10):1123-1130.
PMID: 31582632
The adenosine triphosphate derivatives of 2-oxo-1,3-diazaphenoxazine (dAdapTP) showed a significant discrimination ability for the template strand including that between 8-oxo-2'-deoxyguanosine (8-oxodG) and 2'-deoxyguanosine (dG) by the single nucleotide primer extension...
6.
Horie I, Abiru N, Hongo R, Nakamura T, Ito A, Haraguchi A, et al.
Diabetes Res Clin Pract
. 2017 Nov;
135:178-184.
PMID: 29162514
Aims: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) cause substantially less weight loss than would be expected based on their caloric deficits, probably due to enhanced appetite regulation known as "compensatory hyperphagia,"...
7.
Takeoka A, Tayama J, Kobayashi M, Sagara I, Ogawa S, Saigo T, et al.
Helicobacter
. 2017 Oct;
22(6).
PMID: 29034535
Background: While gastrointestinal function is known to be closely related to psychological status, the influence of Helicobacter pylori-associated atrophic gastritis is currently unknown. We aimed to determine whether atrophic gastritis...
8.
Nozaki A, Ando T, Akazawa S, Satoh T, Sagara I, Horie I, et al.
Endocrine
. 2015 May;
51(1):140-7.
PMID: 26024973
Central diabetes insipidus (CDI) is characterized by polyuria and polydipsia due to a deficiency of vasopressin. Currently, the treatment goal for CDI is improvement of quality of life (QOL) by...